Where cytodigm.com stands, who it competes with, and the keywords that fit its goals: partnerships, investors and recruiting.
cytodigm.com is a well-built, fully crawlable site that search engines have not yet been given a reason to rank. That is an opportunity, not a repair job.
These are the companies a partner or investor will compare Cytodigm to. Notice how little search presence even the leaders have, and how much of it is just people searching their company name.
| Company | Domain | Domain Rating | Ranking keywords | Monthly visits |
|---|---|---|---|---|
| Acuitas Therapeutics | acuitastx.com | 41 | 11 | 149 |
| Arbutus Biopharma | arbutusbio.com | 45 | 41 | 488 |
| Genevant Sciences | genevant.com | 30 | 9 | 38 |
| ReCode Therapeutics | recodetx.com | 35 | 9 | 238 |
| Ethris | ethris.com | 44 | 1 | 15 |
| Polymun Scientific | polymun.com | 38 | 2 | 2 |
| Precision NanoSystems (Cytiva) | precisionnanosystems.com | 52 | 1 | 0 |
Most of their visits come from their own brand names and stock tickers. Almost none come from the science-led searches that new partners type. Nobody in this group owns those searches.
We looked at who holds page one for the searches Cytodigm cares about. These companies are the real search competitors. They are small, and most have a lower Domain Rating than you might expect.
| Company | Domain | Domain Rating | Ranking keywords | Monthly visits |
|---|---|---|---|---|
| Corden Pharma | cordenpharma.com | 54 | 105 | 1,798 |
| Ascendia CDMO | ascendiacdmo.com | 32 | 160 | 1,095 |
| ProGen | progen.com | 37 | 134 | 914 |
| Inside Therapeutics | insidetx.com | 30 | 105 | 807 |
| Ardena | ardena.com | 37 | 105 | 707 |
| Precigenome | precigenome.com | 28 | 82 | 550 |
Chosen for what Cytodigm needs right now: partnership inquiries, investor and media visibility, and recruiting for a growing team.
Volumes are modest because this is a specialist B2B field. That is normal. One qualified partner or investor is worth far more than a thousand general visitors. Difficulty scores are low across the board, which signals real room to rank.
| Keyword | U.S. searches / mo | Difficulty (0–100) | Ad value per click | Page purpose |
|---|---|---|---|---|
| lipid nanoparticle | 1,000 | 5 | $2.50 | Cornerstone “what is an LNP” guide |
| lipid nanoparticles for mrna delivery | 200 | 6 | $6.00 | Applications page |
| lnp formulation | 200 | 0 | $6.00 | Formulation guide |
| lipid nanoparticle manufacturing | 150 | 0 | $7.00 | Scale-up and manufacturing page |
| mrna lnp | 150 | 0 | $3.00 | mRNA delivery explainer |
| lnp delivery | 150 | 5 | $6.00 | Delivery platform overview |
| lipid nanoparticle formulation | 100 | 0 | $5.00 | Formulation page |
| Keyword | U.S. searches / mo | Difficulty (0–100) | Ad value per click | Page purpose |
|---|---|---|---|---|
| in vivo car t | 150 | 0 | $2.50 | In vivo CAR-T delivery page |
| peg lipid | 150 | 0 | $1.60 | Anti-PEG and redosing page |
| mrna delivery | 150 | 0 | $2.50 | Non-viral delivery for mRNA |
| crispr delivery | 100 | 39 | $1.40 | Gene-editing delivery page |
| ionizable lipids | 100 | 1 | $2.50 | Lipid chemistry page |
| sirna delivery | 100 | 8 | $2.50 | siRNA and oligonucleotide delivery |
| anti-peg antibodies | 70 | n/a | $3.50 | Redosable LNP, the Cytodigm difference |
| non-viral gene delivery | 10–70 | n/a | $4.00 | Non-viral delivery overview |
| extrahepatic delivery | 10 | n/a | n/a | Beyond the liver: tissue targeting |
| Keyword | U.S. searches / mo | Difficulty (0–100) | Ad value per click | Page purpose |
|---|---|---|---|---|
| lnp cdmo | 70 | n/a | $2.50 | Partnership and services page |
| lipid nanoparticle technology | 100 | n/a | $4.00 | Technology platform page |
| lipid nanoparticle formulation services | 40 | n/a | n/a | Collaboration page |
| lnp manufacturing | 40 | 0 | $2.50 | Manufacturing partnership |
| lnp drug delivery | 30 | n/a | $3.00 | Drug delivery overview |
| genetic medicine | 150 | 42 | $3.00 | Brand-level positioning page |
“n/a” means Ahrefs shows too little data to score. Those are early, emerging terms where being first matters most. “Ad value per click” is what advertisers pay for the same visitor, a rough guide to commercial value.
Six pages carry most of the opportunity. Each one is written by a person who knows the science and checked against published sources.
| Page | Targets | Why it matters |
|---|---|---|
| What is a lipid nanoparticle? (the complete guide) | lipid nanoparticle, lnp delivery | The single biggest search in the field, and the page that earns links from other sites |
| LNP formulation and manufacturing | lnp formulation, lipid nanoparticle manufacturing | Speaks to partners evaluating a development collaborator |
| Beyond the liver: tissue-specific delivery | extrahepatic delivery, targeted lnp | Your core scientific difference, with little competition |
| Redosable LNPs and the anti-PEG problem | anti-peg antibodies, peg lipid | Answers the question scientists are already asking |
| Delivering in vivo CAR-T | in vivo car t | A fast-growing area with rising interest |
| Cytofinity platform page, rebuilt for search | lnp platform, lipid nanoparticle technology | Turns the product page into a partner-ready landing page |
We would also tune titles and descriptions on the existing 11 pages, add structured data so search engines and AI tools (ChatGPT, Perplexity, Gemini) can identify Cytodigm correctly, and add clear partner calls to action.
Specialist fields move on a longer timeline. These are the checkpoints we would agree on.
| When | What you should see |
|---|---|
| Month 1 | Technical cleanup, tracking set up, six cornerstone pages scoped |
| Months 2–3 | First pages published and indexed; first ranking keywords appear |
| Months 4–6 | Page-one positions on low-difficulty terms; first partner inquiries attributed to search |
| Month 12 | A growing share of visibility across the agreed keyword and AI-answer panels |
Our packages and pricing are on a separate page: Thomas Digital SEO packages. We would recommend starting with the national program that includes AI search.